Capricor Therapeutics (Ondo Tokenized) Price

Capricor Therapeutics Tokenized Stock (Ondo) (CAPRon) is a cryptocurrency. It tokenizes exposure to Capricor Therapeutics shares within Ondo Finance’s global markets infrastructure, operating as a Real World Asset (RWA) across multiple chains.

The token solves cross-border access friction by granting non-U.S. participants the ability to mint and redeem Capricor equities 24 hours a day, five days a week. Each CAPRon coin effectively bundles price performance of the underlying stock with automatic dividend reinvestment, mimicking a total-return swap without the bilateral counterparty risk of an over-the-counter derivative. The design opens U.S. equity exposure to retail and institutional actors whose geographic jurisdiction or brokerage infrastructure previously disqualified them.

Capricor Therapeutics Tokenized Stock (Ondo) operates on the Solana, Ethereum, and BNB Chain networks. The token’s contract instances are deployed across these three environments, ensuring fungibility is maintained through Ondo’s authorized mint-and-burn bridges that lock collateral in trusted custody.

The token implements the ERC-20 interface on Ethereum, the BEP-20 standard on BNB Chain, and the SPL token program on Solana. These implementations preserve full composability with decentralized exchanges, lending protocols, and automated market makers native to each execution layer. The contracts enforce strict minting permissions tied to Ondo’s oracle and brokerage infrastructure, with no public mint function available.

Ondo Finance conceived the tokenized stock product line after launching its structured yield offerings in 2022. The Capricor token appeared as part of the Ondo Global Markets suite, which opened direct on-chain access to individual U.S. equities and ETFs without requiring users to navigate traditional broker-dealer onramps. Early uptake concentrated among crypto-native users in jurisdictions where U.S. equity markets are either operationally cumbersome or regulatory blocked.

The overarching thesis is to collapse the operational distance between global capital markets and decentralized ledger infrastructure. By tokenizing Capricor Therapeutics—along with dozens of other equities—Ondo intends to re-platform equity settlement, shorten trade-to-redeem cycles, and eliminate intermediary layers that historically extracted rent from cross-border flows. The focus remains on permissioned access to precise economic exposure, not on dismantling existing securities frameworks.

Each CAPRon unit acts as a cryptographic receipt for a pro-rata interest in a segregated trust holding Capricor stock. Ondo’s smart contracts algorithmically adjust the token balance per share to reflect dividend accruals, effectively auto-compounding distributions. Redeeming the token for underlying equities requires KYC verification and swaps off-chain with a regulated entity, while purely on-chain transfers convey the synthetic exposure without triggering a taxable realization event in most jurisdictions.

Market makers can exploit the 24/5 mint-and-redeem window to arbitrage pricing discrepancies between on-chain AMM pools and the Nasdaq-listed stock. A DeFi treasury outside the United States might allocate a portion of its stablecoin reserves to CAPRon in order to gain targeted biotechnology sector exposure without opening a brokerage account. Liquidity providers on automated market makers earn swap fees by pairing CAPRon with stablecoins, creating a capital-efficient distribution channel for the tokenized security.

Capricor Therapeutics Tokenized Stock (Ondo) has a total supply of 4.54 tokens. Currently, 4.54 are in circulation. With a market capitalization of $157.22, Capricor Therapeutics Tokenized Stock (Ondo) ranks #12,373 among all cryptocurrencies.